Research Article: Effect of Platelet Parameters on Linezolid-Related Thrombocytopenia in Hospitalized Patients
Abstract:
Linezolid is the first approved fully synthetic oxazolidinone antibacterial drug, in (vancomycin-resistant enterococci-resistant Enterococcus, VRE), methicillin-resistant Staphylococcus aureus (multi-drug-resistant Staphylococcus aureus, MRSA), Mycobacterium tuberculosis (Mycobacterium tuberculosis) infection and other diseases treatment playing a pivotal role in., With the clinical application of linezolid, a wide range of thrombocytopenia caused by same (adverse drug reaction, ADR) has become increasingly prominent, and the risk of treatment failure in patients has increased.
Introduction:
Linezolid is the first approved fully synthetic oxazolidinone antibacterial drug, in (vancomycin-resistant enterococci-resistant Enterococcus, VRE), methicillin-resistant Staphylococcus aureus (multi-drug-resistant Staphylococcus aureus , MRSA), Mycobacterium tuberculosis (Mycobacterium tuberculosis) infection and other diseases treatment playing a pivotal role in. , With the clinical application of linezolid, a wide range of thrombocytopenia caused by same (adverse drug reaction, ADR) has become increasingly…
Read more